What is the typical dosing frequency for nivolumab in adults?

What is the typical dosing frequency for nivolumab in adults?

Nivolumab is a monoclonal antibody used to treat various types of cancer, including melanoma, lung cancer, kidney cancer, and liver cancer. According to its prescribing information, the recommended dosage for nivolumab in adults is 240 mg administered as an intravenous infusion over 30 minutes [1].

How often is nivolumab administered?

Nivolumab is typically administered every 2 weeks for the first 2 years of treatment, then may be continued for up to 12 months longer with a dose adjustment to 480 mg every 4 weeks as needed to maintain clinical benefit.

What happens if I miss a dose?
If a dose of nivolumab is missed, the next dose should be given as soon as possible, but do not take more than one dose in a 24-hour period unless directed by your healthcare provider.

What are the common dosing regimens for nivolumab?

The typical dosing regimens for nivolumab in adults are:

- 240 mg every 2 weeks for the first 2 years, then 480 mg every 4 weeks as needed for up to 12 months longer.
- For patients who have not had disease progression and are continuing treatment beyond 2 years, the nivolumab dose may be increased to 480 mg every 4 weeks as needed to maintain clinical benefit.

Please note that nivolumab dosing may vary depending on individual patient characteristics and disease status. Consult your healthcare provider or the official prescribing information for detailed dosing guidance.

References:
[1] Bristol-Myers Squibb. (2022). Opdivo (Nivolumab). Prescribing Information.